FDA Approves a Combination of Drugs for Diffuse Large B-cell Lymphoma

  Diffuse large B-cell lymphoma  (DLBCL) is a common type of non-Hodgkins lymphoma. World Pharma News recently reported that the FDA approved the first chemoimmunotherapy, Polivy, for DLBCL in combination with…

Continue Reading FDA Approves a Combination of Drugs for Diffuse Large B-cell Lymphoma
Zap! New Genetic Therapy Technique Electrocutes Cancer Cells into Submission
Source: Pixabay.com

Zap! New Genetic Therapy Technique Electrocutes Cancer Cells into Submission

In a Washington Post article by Ben Guarino, new cancer treatments lasso the power of naturally occurring immune cells in the body. Researchers are looking into ways modify them to…

Continue Reading Zap! New Genetic Therapy Technique Electrocutes Cancer Cells into Submission
Close Menu